维普期刊资源整合服务平台（V6.5）

156篇 您的检索式：作者名="Reardon DA"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Diagnosis and treatment of high-grade astrocytoma显示文摘	Sathornsumetee S Rich JN Reardon DA		0，，04：	1
2	Diagnosis and treatment of high-grade astrocytoma 显示文摘	SATHORNSUMETEE S RICH JN REARDON DA	2007	Neurol Clin2007，25，4：	1
3	Human cardiac explantation and autotransplantation:application in a patient with a large cardiac pheochromocytoma显示文摘	Cooley DA Reardon MJ Frazier OH		0，，02：	1
4	Phase Ⅱ trial of irinotecan plus celecoxib in adults with recurrent malignant glioma 显示文摘	Reardon DA Quinn JA Vredenburgh J	2005	Cancer2005，103，2：	1
5	Diagnosis and treatment of high-grade astrocytoma显示文摘	Sathornsumetee S Rich JN Reardon DA	2007	Neurol Clin2007，25，4：	1
6	Phase Ⅱ trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas显示文摘	Reardon DA Akabani G Coleman RE	2002	J Clin Oncol2002，20，：	1
7	Experience with irinotecan for the treatment of malignant glioma显示文摘	Vredenburgh JJ Desjardins A Reardon DA	2009	Neuro- Oncology2009，11，1：	1
8	Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma:PhaseⅠ trial results显示文摘	Reardon DA Quinn JA Akabani G	2006	J Nucl Med2006，47，：	1
9	Phase II trim of temozolomide in patienfs with progressive low-grade g-ioma显示文摘	Quinn JA Reardon DA Friedman AH	2003	J Clin Oncol2003，21，4：	1
10	Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group 显示文摘	Wen PY Macdonald DR Reardon DA	2010	J Clin Oncol2010，28，11：	1
11	Phase II trialof temozolomide in patients with progressive low-gradeglioma 显示文摘	Quinn JA Reardon DA Friedman AH	2003	J Clin Oncol2003，21，：	1
12	Cilengitide : an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme 显示文摘	Reardon DA Nabors LB Stupp R	2008	Expert Opin Investig Drugs2008，17，8：	1
13	Randomized Phase II Study of Cilengitide,an Integrin Targeting Arginine-Glycine-Aspartic Acid Peptide,in Recurrent Glioblastoma Multiforme显示文摘	Reardon DA Fink K Nabors LB	2008	J Clin Oncol2008，26，34：	1
14	Cilengitide:an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme显示文摘	Reardon DA Nabors LB Stupp R	2008	Expert Opin Investig Drugs2008，17，8：	1
15	Phase Ⅱ trial of gefitinib in recurrent glioblastoma显示文摘	Rich JN Reardon DA Peery T	2004	J Clin Oncol2004，22，：	1
16	Phase 2 study of carbopl- atin, irinotecan, and bevaeizumab for recurrent glioblastoma after pro- gression on bevacizumab therapy显示文摘	Reardon DA Desjardins A Peters KB	2011	Cancer2011，117，23：	1
17	Phase II trial of temozolomide in patients with progressive low- grade glioma显示文摘	Quinn JA Reardon DA Friedman AH	2003	J Clin Oncol2003，21，：	1
18	Clinical experience with alpha-particle emitting 211At:treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6显示文摘	Zalutsky MR Reardon DA Akabani G		0，，1：	1
19	Tar-geted a-particle radiotherapy with 211 At-labeled monoclonal antibodies显示文摘	Zalutsky MR Reardon DA Pozzi OR	2007	Nucl Med Biol2007，34，：	1
20	Recent advances in the treatment of malignant astrocytoma显示文摘	Reardon DA Rich JN Friedman HS	2006	J Clin Oncol2006，24，8：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示